Disclosure Of First-Time Adoption [Text Block]

Oxford Biomedica PLC - Filing #5873328

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
39 9, 500 GBP
394 ,85 6 GBP
52 ,98 1 GBP
3 ,44 1 GBP
3, 268 GBP
57 ,04 6 GBP
9 76 GBP
6 ,41 7 GBP
60 ,48 7 GBP
77,8 34 GBP
35 2, 918 GBP
3 ,82 8 GBP
38 0, 333 GBP
48, 40 3 GBP
3,95 6 GBP
2, 291 GBP
8,0 59 GBP
74 ,00 6 GBP
23 6,1 92 GBP
35, 00 3 GBP
3 1,5 39 GBP
379, 95 3 GBP
1 98, 545 GBP
48 ,13 2 GBP
7, 825 GBP
20 4, 653 GBP
2, 291 GBP
Comprehensive income
43 ,87 8 GBP
- GBP
- GBP
6 88 GBP
43 ,1 90 GBP
5 ,4 68 GBP
4 9,3 46 GBP
- GBP
- GBP
18 9,4 69 GBP
1 61, 35 9 GBP
2 8,1 10 GBP
15 7,4 90 GBP
- GBP
3 ,86 9 GBP
- GBP
- GBP
- GBP
Profit (loss)
4 3,1 90 GBP
- GBP
- GBP
- GBP
43 ,1 90 GBP
5,4 19 GBP
4 8,6 09 GBP
- GBP
- GBP
18 4,1 62 GBP
15 7,4 90 GBP
2 6,6 72 GBP
157 ,4 90 GBP
- GBP
- GBP
- GBP
- GBP
- GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.